Joshua B Cohen Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 7 hours ago
Joshua B Cohen has an estimated net worth of at least $34.8 million*, as of yesterday. They own 3.4 million shares of AMLX stock. They have sold 179,940 shares of AMLX stock since 2021, for an estimated $3.8 million.
Joshua B Cohen $AMLX SEC Form 4 Insider Trading
Joshua B Cohen has filed a total of 11 insider trades in $AMLX since 2021. Their most recent trade was a sale of 21,490 shares, made on Mar 31, 2025. Their largest trade was a sale of 96,076 shares, made on Mar 16, 2023. We estimate that they now own 3.4 million shares of $AMLX, worth an estimated $31.0 million.
Insider Trading at $AMLX
There have been a total of 109 insider trades reported at $AMLX since 2021, with 2.8 million shares purchased and 2.9 million shares sold. The most active insider traders in $AMLX stock have been Gina Mazzariello, Joshua B Cohen, and Justin B. Klee. The most recent trade was a sale of 15,000 shares reported by Gina Mazzariello (Chief Legal Officer), made on Aug 13, 2025.
History of Insider Stock Trades by Joshua B Cohen
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 21,490 | Mar 31, 2025 | April 2, 2025, 4:57 p.m. |
![]() |
Sale | 4,595 | Mar 03, 2025 | March 5, 2025, 5:32 p.m. |
![]() |
Sale | 11,851 | Feb 03, 2025 | Feb. 5, 2025, 5:55 p.m. |
![]() |
Sale | 7,471 | Jan 06, 2025 | Jan. 8, 2025, 6:26 p.m. |
![]() |
Sale | 18,589 | Sep 30, 2024 | Oct. 2, 2024, 6:53 p.m. |
![]() |
Sale | 4,135 | Mar 05, 2024 | March 7, 2024, 5:05 p.m. |
![]() |
Sale | 5,841 | Jan 09, 2024 | Jan. 11, 2024, 6:10 p.m. |
![]() |
Sale | 96,076 | Mar 16, 2023 | March 20, 2023, 8:21 p.m. |
![]() |
Sale | 3,924 | Mar 16, 2023 | March 20, 2023, 8:21 p.m. |
![]() |
Sale | 1,846 | Jan 06, 2023 | Jan. 10, 2023, 8:20 p.m. |
![]() |
Sale | 4,122 | Jan 06, 2023 | Jan. 10, 2023, 8:20 p.m. |
$AMLX Executives and Stock Owners with Insider Trades
-
Gina Mazzariello, Chief Legal Officer
-
Joshua B Cohen, Co-Chief Executive Officer
-
Justin B. Klee, Co-Chief Executive Officer
-
James M Frates, Chief Financial Officer
-
Patrick D Yeramian, Chief Medical Officer
-
Camille L Bedrosian, Chief Medical Officer
-
Margaret Olinger, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.